William Blair initiated coverage of Arxis (ARXS) with an Outperform rating. The firm sees over 20% upside to shares over the next year based on the company achieving its high-single-digit organic sales and double-digit EBITDA growth targets. Arxis can achieve “industrial compounder status, which can lead to multiple expansion closer to its faster-growing peers,” the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARXS:
- Arxis Initiated at Buy on Diversified Defense & Industrial Platform, Expanding Margins, and 20%+ Upside Potential
- Arxis initiated with a Buy at Rothschild & Co Redburn
- Arxis initiated with an Overweight at Morgan Stanley
- Arxis initiated with an Outperform at Baird
- Arxis initiated with a Buy at Goldman Sachs